#316 Biotech Innovations Transforming Cancer Diagnosis, with Guido Baechler

This week, James is joined by Dr Guido Baechler, CEO and Director at Mainz Biomed, a leading developer of market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection test for colorectal cancer.

Guido has 30 years of global experience leading public & private life science companies, having held senior executive roles at Singulex and SummerBio, and at Roche, where he led Roche Molecular’s global program management.